创业板，增量资金来了

Core Viewpoint - The launch of the Omnifund Easyway ChiNext ETF on the Singapore Exchange marks a significant step in the cross-border investment landscape, providing international investors with easier access to China's ChiNext market, which focuses on innovative and emerging industries [1][2]. Group 1: ETF Launch and Market Access - The Omnifund Easyway ChiNext ETF is the fourth Chinese asset ETF listed on the Singapore Exchange since the establishment of the Shenzhen-Singapore ETF mutual access program in 2022 [1]. - A total of 10 ChiNext-related ETFs have now been listed on various overseas exchanges, achieving comprehensive coverage across major economies in Asia, Europe, North America, and South America [1]. - The ETF tracks the ChiNext Index, which represents a significant benchmark for China's A-share market, with over 90% of its weight in strategic emerging industries [1]. Group 2: Industry Growth and Investment Opportunities - The ChiNext Index includes leading companies in sectors such as new generation information technology, new energy vehicles, and biotechnology, featuring firms like CATL, Huichuan Technology, and Mindray Medical [1]. - Since 2021, the index's constituent stocks have shown strong fundamental growth, with compound annual growth rates of 21% in revenue and 14% in net profit [1]. - The ChiNext market is characterized by high market vitality and elasticity, making it a frontline area for emerging industries, with significant long-term investment value [3]. Group 3: Future Developments and Strategic Goals - The mutual access mechanism for ETFs between China and Singapore is expected to continue expanding, with plans for more diversified cross-border investment tools [2][3]. - The Shenzhen Stock Exchange aims to attract more long-term foreign capital to invest in the Chinese market, enhancing its international influence [3].